The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
Figure 3
Images of the left eye 12 months after the third ranibizumab injection. (a) Color fundus photo shows retinal hemorrhage surrounding a CNVM, hyperpigmented macular RPE, and peripheral RPE hypopigmentation. (b) Fluorescein angiography shows a CNVM and hyperfluorescent, peripheral RPE changes. (c) Optical coherence tomography shows a parafoveal CNVM with a significantly increased amount of intraretinal fluid (compare with Figure 2(b)).
